| Date Filed | Type | Description |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2020 |
3
| Shapiro David (Director) has filed a Form 3 on Galecto Inc. |
| 09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Sold 2,000 shares
@ $86.28, valued at
$172.6k
Exercised 2,000 options to buy
@ $31.9, valued at
$63.8k
|
|
| 04/16/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Sold 2,000 shares
@ $95, valued at
$190k
Exercised 2,000 options to buy
@ $31.9, valued at
$63.8k
|
|
| 04/03/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 482 shares
@ $111.5, valued at
$53.7k
Sold 562 shares
@ $115.01, valued at
$64.6k
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 3,300 shares
@ $0
Granted 5,300 options to buy
@ $110.8, valued at
$587.2k
|
|
| 01/04/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Sold 474 shares
@ $97.48, valued at
$46.2k
|
|
| 01/03/2019 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 736 shares
@ $100.79, valued at
$74.2k
Sold 2,000 shares
@ $98.28, valued at
$196.6k
Sold 699 shares
@ $97.45, valued at
$68.1k
Exercised 2,000 options to buy
@ $31.9, valued at
$63.8k
|
|
| 12/19/2018 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Sold 2,000 shares
@ $106.62, valued at
$213.2k
Exercised 2,000 options to buy
@ $31.9, valued at
$63.8k
|
|
| 12/06/2018 |
4
| Shapiro David (Director) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 46,500 options to buy
@ $1.01, valued at
$47k
Granted 30,000 options to buy
@ $1.01, valued at
$30.3k
|
|
| 12/06/2018 |
3
| Shapiro David (Director) has filed a Form 3 on ORGANOVO HOLDINGS, INC. |
| 11/02/2018 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Sold 2,000 shares
@ $96.32, valued at
$192.6k
Exercised 2,000 options to buy
@ $21.5, valued at
$43k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2018 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Sold 4,917 shares
@ $111.428, valued at
$547.9k
|
|
| 02/22/2018 |
4
| Shapiro David (Chief Medical Officer) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Granted 2,900 shares
@ $0
Granted 4,400 options to buy
@ $58.74, valued at
$258.5k
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Shapiro David (CMO and EVP - Development) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Granted 6,000 shares
@ $0
Granted 10,000 options to buy
@ $107.18, valued at
$1.1M
|
|
| 01/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|